Systemic lupus erythematosus and pregnancy

A Lateef, M Petri - Rheumatic Disease Clinics, 2017 - rheumatic.theclinics.com
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease with a strong
female predilection. Disease onset in a younger age group, coupled with improved survival …

Antirheumatic medications in pregnancy and breastfeeding

MB Talabi, MEB Clowse - Current opinion in rheumatology, 2020 - journals.lww.com
Current Opinion in Rheumatology Log in or Register Subscribe to journalSubscribe Get
new issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle …

Anti‐TNF treatment during pregnancy and birth outcomes: a population‐based study from Denmark, Finland, and Sweden

G Bröms, H Kieler, A Ekbom, M Gissler… - … and Drug Safety, 2020 - Wiley Online Library
Purpose To study the risk of preterm birth, caesarean section, and small for gestational age
after anti‐tumor necrosis factor agent treatment (anti‐TNF) in pregnancy. Methods …

Fertility and pregnancy outcomes in women with spondyloarthritis: a systematic review and meta-analysis

S Hamroun, A Hamroun, JJ Bigna, E Allado… - …, 2022 - academic.oup.com
Objective The aim of this study was to determine the impact of SpA and its treatments on
fertility and pregnancy outcomes, as well as the impact of pregnancy on disease activity …

Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study

RJ Desai, BT Bateman, KF Huybrechts, E Patorno… - Bmj, 2017 - bmj.com
Objective To compare the risk of serious infections associated with use of systemic steroids,
non-biologic agents, or tumor necrosis factor α (TNF) inhibitors in pregnancy. Design …

The time of equipoise on the use of biological DMARDs in for inflammatory arthritis during pregnancy is finally over: a reappraisal of evidence to optimise pregnancy …

I Giles, I Thorne, NS Schmidt, C Reid… - The Lancet …, 2024 - thelancet.com
Active inflammatory arthritis in pregnancy is associated with an increased risk of adverse
pregnancy outcomes. Treatment of active inflammation and maintenance of low disease …

Systemic lupus erythematosus and pregnancy

M Petri - Rheumatic Disease Clinics of North America, 1994 - Elsevier
Lupus pregnancy is, by definition, high risk because of the frequency of adverse fetal
outcomes, including fetal loss, preterm birth, neonatal lupus (including congenital heart …

Exploring the preferences of women regarding sexual and reproductive health care in the context of rheumatology: a qualitative study

T Wolgemuth, OM Stransky, A Chodoff… - Arthritis care & …, 2021 - Wiley Online Library
Objective To explore the sexual and reproductive health (SRH) care and counseling needs
of young women with rheumatic diseases in the context of their rheumatology care. Methods …

Pregnancy and infant outcomes including major congenital malformations among women with chronic inflammatory arthritis or psoriasis, with and without etanercept …

WJ Carman, NA Accortt, MS Anthony… - … and Drug Safety, 2017 - Wiley Online Library
Purpose Objectives were to quantify prevalence estimates of pregnancy and infant
outcomes including major congenital malformations (MCMs) by etanercept (ETN) exposure …

Serious infections in rheumatoid arthritis offspring exposed to tumor necrosis factor inhibitors: a cohort study

É Vinet, C De Moura, CA Pineau… - Arthritis & …, 2018 - Wiley Online Library
Objective To evaluate the risk of serious infections in rheumatoid arthritis (RA) offspring
exposed to tumor necrosis factor inhibitors (TNFi) in the gestational period compared to …